Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time Restricted Eating for Patients With Early Stage Breast Cancer Receiving Neoadjuvant Chemotherapy

NCT05327608 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05327608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05327608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time Restricted Eating for Patients With Early Stage Breast Cancer Receiving Neoadjuvant Chemotherapy
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2022
Completion date
May 1, 2027
Enrollment
55 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, invasive breast carcinoma